Treatment of Colchicine-Resistant Familial Mediterranean Fever With Anakinra

AuthorVadood Javadi Parvanehen
AuthorReza Shiarien
OrcidReza Shiari [0000-0001-6906-1053]en
Issued Date2015-07-01en
AbstractIntroduction: Familial Mediterranean Fever (FMF) is an auto-inflammatory disease presenting with periodic fever and various clinical manifestations. Almost 10% of the patients with FMF do not respond to colchicine therapy. Case Presentation: Herein was reported a colchicine non-responsive patient with accurate diagnosis and early treatment of FMF. She had presented with recurrent and persistent acute abdominal pain attacks and several abdominal surgeries. Addition of recombinant interleukin-1 receptor antagonist (Anakinra) to colchicine was effective to decrease the number and severity of abdominal pain in the patient. Conclusions: This case showed the effect of additional Anakinra on children with FMF who were colchicine resistant.en
DOIhttps://doi.org/10.5812/pedinfect.21664v2en
KeywordFamilial Mediterranean Feveren
KeywordColchicineen
KeywordInterleukin-1 Receptor Antagonist Proteinen
PublisherBrieflandsen
TitleTreatment of Colchicine-Resistant Familial Mediterranean Fever With Anakinraen
TypeCase Reporten

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
20254-pdf.pdf
Size:
64.95 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF